The UK Medical Device Regulation (UK MDR) is vital for ensuring the safety, performance and quality of medical devices in the UK. However, the regulatory landscape for medical devices in the UK has undergone substantial changes post-Brexit, presenting new, and ever-changing, challenges for manufacturers.   

Jointly hosted by TOPRA and RAPS, the 2025 UK MDR Regulatory Conference was a two-day event, held on 5 and 6 November 2025, which offered a deeper understanding of the UK MDR and its impact on the current regulatory landscape. With a primary focus on regulatory innovation, it explored how the adoption process is developing and what mechanisms are in place to support the introduction of high value-added new products which have the potential to both enhance outcomes for patients and drive operational efficiency in the NHS. 

This article outlines some of the topics covered and key insights for industry.